Verastem (VSTM) Total Debt Growth (1y) (2018 - 2026)
Verastem (VSTM) Total Debt Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 2.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30% |
| Dec 31, 2025 | 87.43% |
| Sep 30, 2025 | 92.82% |
| Jun 30, 2025 | 84.23% |
| Mar 31, 2025 | 78.14% |
| Dec 31, 2024 | 1.59% |
| Sep 30, 2024 | 1.52% |
| Jun 30, 2024 | 1.45% |
| Mar 31, 2024 | 1.39% |
| Dec 31, 2023 | 63.44% |
| Sep 30, 2023 | 63.58% |
| Jun 30, 2023 | 63.70% |
| Mar 31, 2023 | 63.82% |
| Sep 30, 2020 | 28.94% |
| Jun 30, 2020 | 15.52% |
| Mar 31, 2020 | 42.26% |
| Dec 31, 2019 | 39.03% |
| Sep 30, 2019 | 39.25% |
| Jun 30, 2019 | 39.34% |
| Mar 31, 2019 | 66.39% |